taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said..
.
.
..
latest., seventh-highest in the nation, and more than double the national average..treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic).